A study to evaluate if siddha medicine can help reduce weight and body measurements in people with moderate obesity

An open labelled single centric prospective clinical trial for evaluating the therapeutic efficacy of a Siddha regimen in the management of Athithoolam Atitula noy obesity Class I and II - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/088981

Enrollment

Registered

2025-06-17

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E669- Obesity, unspecified

Interventions

Intervention1: Karunjeeraga Chooranam Naththaichoori chooranam Kukil parpam tablet: Karunjeeraga Chooranam 2 gm Naththaichoori chooranam 2 gm Kukil parpam tablet 2 nos Will be given twice a day for 4

Eligibility

Inclusion criteria

Inclusion criteria: K/C/O Diabetes Mellitus Obesity BMI greater than or equal to 30 kg/m^2 Obesity class I BMI 30 to 34.9 kg/m^2 Obesity class II BMI 35 to 39.9 kg/m^2

Exclusion criteria

Exclusion criteria: Vulnerable groups (Pregnancy and lactation) Hypothyroidism Malignancy The patient is not willing to undergo laboratory investigations

Design outcomes

Primary

Measure	Time frame
A 5 to 10 percent reduction in BMI and a reduction in anthropometric measurements from baseline to endpointTimepoint: 103 days	—

Secondary

Measure	Time frame
To assess the difference in laboratory parameters and Enhanced Quality of Life from baseline to endpointTimepoint: 103 days	—

Countries

India

Contacts

Public ContactDr G Senthilvel

National Institute of Siddha

siddha.senthilvel@gmail.com8925856333

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026